FDA - Food and Drug Administration

Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy

'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic discovery with the uncompromising quality of a global pharmaceutical leader.'

In this photo illustration, a smartphone displays the logo of Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company specializing in diabetes care, obesity treatment, in front of a screen showing the company's latest stock market chart, January 29, 2026
US HEALTH and Human Services Secretary Robert F. Kennedy Jr.

RFK Jr.’s health department ordered withdrawal of studies showing vaccine efficiency - report

A person cups their hand to their ear in an act of listening (illustrative)

'Miracle cure': 2-year-old steals show at White House announcement of hearing loss therapy approval

 U.S. President Donald Trump signs an executive order encouraging more research into ibogaine, next to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., Joe Rogan, and Americans for Ibogaine CEO W. Bryan Hubbard, in the Oval Office of the White House in Washington, D.C., April 18

Trump signs order to accelerate Ibogaine research for veterans with PTSD 


Israel's DreaMed gets FDA clearance for diabetes solution

Israeli company DreaMed Diabetes AI developed Advisor Pro, a decision support system to assist healthcare providers in the management of diabetes patients with insulin pumps or injections.

A blood glucose test is done to check sugar levels in a Type 2 Diabetes patient

FDA decision to limit COVID booster shots didn't satisfy anyone - opinion

The FDA approved the COVID-19 booster shot only for high-risk patients and people over 65, which is not the answer Pfizer, the US and Israel wanted to hear.

 A WOMAN receives a third dose of the COVID-19 vaccine in Tel Aviv in August

US eyes IDF soldiers' data for Pfizer COVID-19 booster safety

US health officials are hoping data on Israeli military personnel can help clarify the risk of heart muscle inflammation in younger people who have received Pfizer/BioNTech COVID-19 booster shots.

An illustrative photo of the Pfizer COVID-19 vaccine.

Pfizer seeks FDA clearance for COVID-19 vaccine in younger children

The vaccine, which is already authorized in teens aged 12 to 15 and fully approved for ages 16 and up, has been shown to induce a strong immune response in the target age group.

Pfizer

COVID-19: FDA to authorize Pfizer booster vaccine for older Americans

Advisers to the FDA voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older.

Signage is seen outside of FDA headquarters in White Oak, Maryland.

Pfizer says vaccine safe, effective for kids 5-11, will apply for EUA

“Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine,” said company CEO Albert Bourla in a release.

A NURSE draws up a COVID-19 vaccine dose at a Magen David Adom vaccination center in Jerusalem earlier this month.

Was Israel’s decision to give everyone COVID boosters a shot in the dark?

Some parents are now questioning if Israel didn’t rush too fast to jab their children.

An elderly Israeli is seen receiving the third COVID-19 booster shot at a Clalit clinic in Jerusalem, on August 1, 2021.

FDA advisers vote unanimously to give COVID booster to people 65+

US health experts say not enough evidence to give third shot to younger people, as Israel boasts crossing 3 million with the booster.

 People waiting in line at an MDA station to receive their coronavirus vaccines in Tel Aviv, August 14 2021

COVID-19: Israel to present booster shot data to FDA experts

So far 2.6 million people out of a population of 9.3 million have received three doses of the Pfizer vaccine in Israel.

 Third vaccine doses being administered at the Amigdor Retirement Residence by Magen David Adom (MDA), Jerusalem, August 5, 2021.

Pfizer starts process to seek US approval of COVID-19 vaccine booster

Pfizer Inc on Wednesday began the process for full approval of its COVID-19 booster dose in the United States.

A healthcare worker hands over doses of the Pfizer-BioNTech COVID-19 vaccine to a doctor at Messe Wien Congress Center, which has been set up as coronavirus disease vaccination centre, in Vienna, Austria February 7, 2021.